Biotech · Private company
Taiho Pharmaceutical Co., Ltd.
Track this companyFree. Adds Taiho Pharmaceutical Co., Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials93 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- TAS0953/HM06Phase 2 · RET-altered Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- A Bioequivalence Study Between Two Casdatifan Tablet Strengths and Food Effect Study of Casdatifan in Healthy Adult ParticipantsPHASE1 · COMPLETED · started May 29, 2026ClinicalTrials.gov NCT07641881 · fetched Nov 12, 2026
- Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal AdenocarcinomaPHASE3 · ACTIVE_NOT_RECRUITING · started Dec 13, 2024ClinicalTrials.gov NCT06608927 · fetched Nov 12, 2026
- A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the BodyPHASE3 · COMPLETED · started Nov 21, 2022ClinicalTrials.gov NCT05568095 · fetched Nov 12, 2026
- Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon AdenocarcinomasPHASE1 · RECRUITING · started Aug 26, 2021ClinicalTrials.gov NCT04920032 · fetched Nov 12, 2026
- Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene AbnormalitiesPHASE1_PHASE2 · RECRUITING · started Dec 16, 2020ClinicalTrials.gov NCT04683250 · fetched Nov 12, 2026
- TAS-102 With Concurrent Radiation for the Treatment of Untreated Resectable Stage II-III Rectal CancerPHASE1 · COMPLETED · started Dec 11, 2019ClinicalTrials.gov NCT04104139 · fetched Nov 12, 2026
- TAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal AdenocarcinomaPHASE1 · COMPLETED · started Aug 26, 2019ClinicalTrials.gov NCT04074343 · fetched Nov 12, 2026
- Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETsPHASE1 · TERMINATED · started Aug 22, 2017ClinicalTrials.gov NCT02943733 · fetched Nov 12, 2026
- Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver MetastasesPHASE1 · COMPLETED · started Jan 9, 2017ClinicalTrials.gov NCT02602327 · fetched Nov 12, 2026